Australia's Nova Eye Medical soars on FY26 sales forecast upgrade

Nova Eye Medical

05/05/2026 03:54

** Shares of Nova Eye Medical EYE.AX rise as much as 8% to A$0.135, post their steepest intraday pct gain since April 28

** Medical tech co upgrades forecast for FY26 sales, excluding China, to $22 million–$23 million from $21 million-$22 million previously expected

** Reports last 12-month sales, excluding China, of $21.6 million as of April 30, with two months of FY26 still to run

** About 861,000 shares change hands, 3.7 times the 30-day avg

** Stock up 2% YTD, including the session's moves

($1 = $1.0000)

(Reporting by Anjali Singh in Bengaluru)

((anjali.singh2@thomsonreuters.com;))